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Using [3H]diazepam binding, high concentrations of receptors were found in the frontal cortex and lateral amygdala. Infusions ol 
chlordiazepoxide into the lateral amygdala induced a release of responding measured during the component of a conditioned emotion- 
al response task previously associated with an aversive stimulus. The lateral amygdala appears to be an important component of the 
forebrain circuitry involved in the expression of anxiety and sensitive to benzodiazepine drugs. 
INTRODUCTION 
The amygdaloid  complex has long been identif ied 
as an important  centre for the regulat ion of emotion-  
al behaviour  4. Weiskrantz  originally suggested that 
the effect of amygdalec tomy in monkeys  tested on 
avoidance tasks was to make it difficult for animals to 
identify reinforcing stimulP 2. Later  recording 22 and 
lesion studies in monkeys  7`u and rats 23 have support-  
ed the idea of an amygdaloid  mechanism for evaluat-  
ing the motivat ional  significance of sensory stimuli. 
Lesions and disruptive electrical s t imulat ion of the 
amygdaloid complex in rats selectively release spon- 
taneous and condi t ioned avoidance behaviour ,  indi- 
cating that the amygdaloid  complex in this species is 
perhaps most critically involved in the evaluat ion of 
aversive stimuli -~,<27. One of the most striking and 
characterist ic behavioural  effects of benzodiazepine  
drugs is also to release behaviour  suppressed by aver- 
sive stimuli such as electric shock~. The present  ex- 
per iments  test the hypothesis  that activation of ben- 
zodiazepine receptors  concent ra ted  within the amyg- 
daloid complex would produce anxiolytic effects. 
The distr ibution of benzodiazepine  receptors  in the 
amygdaloid complex and other  major  components  of 
the limbic system was es t imated primari ly to provide 
a guide for complementa ry  microinfusion experi-  
ments, and also as an addit ional  comparison with 
mapping studies from other  laborator ies  >. The be- 
havioural effects of microinfusions of benzodiaze-  
pines into subregions of the amygdaloid  complex rich 
in receptors  were measured using a 'conflict" test> 
modified for intracerebral  microinfusion studies 27. 
The modified test is sensitive to benzodiazepines  ad- 
ministered parentera l ly  and to b lockade of these ef- 
fects by the benzodiazepine  :antagonist Ro 15-1788, 
allows repeated  drug t rea tments  on a stable baseline,  
yet requires only 8 sessions of training2:.-'< 
The effects of the in t ra-amygdaloid  infusions on 
pain threshold in the tail-flick test were also meas- 
ured to evaluate the possible analgesic effects -'1 of 
BZ at doses showing an anxiolytic action, [3H]Diaze- 
pare was used for the binding studies, but as the etha- 
nol /propylene glycol/saline solvent vehicle necessary 
for i.v. adminis trat ion of d iazepam was unsuitable for 
direct intracerebral  infusion, the water-soluble com- 
pound chlordiazepoxide was used for the infusion ex- 
periments.  
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MATERIALS AND METHODS 
[3 H] Diazepam binding 
Animals were killed by decapitation. The brain 
was exposed by a single median sagittal scissor cut 
through the skull and retraction of the cranial bones. 
The brain was removed on a spatula and positioned 
ventral surface uppermost on an ice-cooled stainless 
steel plate. Transections and finer cuts were made 
with mounted razor blades, and the tissue manipu- 
lated with fine forceps. The dissection typically took 
4-5 min to generate samples of frontal cortex, stria- 
turn, septum, hypothalamus, hippocampus, amygda- 
loid complex, entorhinal cortex, cerebellum, brain- 
stem and spinal cord. Samples were frozen immedi- 
ately on aluminium foil overlying solid CO, and then 
stored in polythene vials. Subregions of the amygda- 
loid complex were dissected from frozen sections on 
a freezing-stage microtome (Frigistor). Frozen 
brains were transferred from liquid nitrogen, trun- 
cated posteriorly and placed anterior surface upper- 
most on the freezing-stage. Four successive sections 
of 500 #m thickness were then cut through successive 
levels of the amygdaloid complex, beginning at the 
level of the anterior commissure (0.0 in the atlas of 
Pellegrino and Cushmanlg). 
As each section was exposed, 4 subregions of the 
amygdaloid complex (lateral, basolateral, central- 
medial and cortical) were dissected out under a bin- 
ocular microscope with fine scalpel blades (Swarm- 
Morton No. 11), using the anterior commissure, op- 
tic tract and lateral ventricle as landmarks. 
Frozen tissue was homogenized to 10 mg.ml-~ in 
50 mM Tris/HCI (Trizma) buffer (pH 7.4) at 4 °C. 
Pre-cooled assay reagents were then added to assay 
tubes in an ice bath at 4 °C. Final concentrations of 
the reagents in the assay (200/~1 total volume) were, 
in order of addition: tissue homogenate 10 mg'ml-~, 5 
micromolar 'cold' diazepam (Roche) or de-ionized 
water, and 10 nM [3H]diazepam (3.22 TBq/mmol, or 
87 Ci/mmol, Amersham Radiochemicals). Assay 
tubes, replicated in triplicate, were incubated for 45 
min at 4 °C. Tube contents were transferred to a 12- 
port binding manifold (Millepore) in two 5 ml washes 
of 50 mM Tris, and vacuum filtered (minimum vacu- 
um 20 mm Hg: Whatman GF/C filters). Filters were 
removed and dried in a jet of warm air for a minimum 
of 60 min, then immersed in scintillation fluid corn- 
posed of 4.2 g PPO (2.5-diphenyloxazole) and 50 mg 
PDPOP (1,4-bis-2-5-phenyl-oxazolyl-benzcnet per 
titre of sulphur-free toluene. Samples were then 
counted to constant period (10 min) on an Isocap 30() 
liquid scintillation counter (Nuclear Chicago). lhc 
ESP-variable quench mode of a more sophisticated 
counter (Searle Model 688(I MK. 3) was used to 
check quench. Quench was sufficiently low and con- 
stant for the direct use of untransformed counts per 
minute (cpm) data to be used in subsequent cal- 
culations. The range of tissue counts was 100i)- 
22,000 cpm, with filter blanks typically below 1()11 
cpm. Bound radioactivity in cpm was conx.erted to 
binding density in fmol per mg tissue (w. wt.): the ref- 
erence standard was always 2 pmol of ligand spotted 
directly onto the filter. Each data point was the mean 
of the 3 assay replicates, the samples for which were 
all based on a minimum of 6 pooled samples. 
Two methods were employed to estimate maximal 
specific receptor binding in the brain regions as- 
sayed: the estimates of choice were based on extra- 
polation from Scatchard plots, but where this was im- 
practical, as in the case of very small intra-amygda- 
loid samples, relative estimates of binding density 
were made at fixed ligand concentration. 
Conflict test 
Rats (n = 11) were first trained to press a lever on 
an FR1 schedule in a standard conditioning chamber 
All animals then received a 20-min conditioning ses- 
sion each day for 8 days. Each session was parti- 
tioned into alternating 5-rain light (L} and 2.5-rain 
dark (D) periods in a fixed LDLDL sequence Dur- 
ing both periods (L,D), every lever-press delivered a 
food pellet; in the dark periods only, a random 50% 
of lever-presses also elicited a footshock ~0.6 mA. 
0.5 s). All conditioning contingencies were con- 
trolled by BASIC programs running on a low-cost 
laboratory microcomputer (Acorn). All drugs were 
administered i.p. in 0.9% saline. Animals were test- 
ed in extinction sessions (i.e. shock offI separated by 
1 or 2 sessions of re-training to maintain baseline re- 
sponding. Results are expressed as mean lever-pres- 
sing rates over the 5-min periods. The Wilcoxon test 
was used throughout for statistical comparisons. 
Analgesia test 
Rats (n = 11) were lightly restrained and their tails 
positioned in a groove over a 1 cm hole shielded from 
a 1 kW heat lamp positioned 6 in. below it. The shield 
plate was then removed to expose the 1 cm hole and 
the latency for the rat to flick its tail away from the 
heat source measured with a stopwatch. 
RESULTS 
Binding 
Specific binding was saturable and linear around 
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Fig. 1. Estimates of [~Hldiazcpam binding density in various re- 
gions of rat brain and within the amygdaloid complex. A: esti- 
mates from Scatchard pk)ts. B: estimates taken at 10 nM ligand 
concentration (means I s.c.s.,  n - 6). FC, frontal cortex; HE. 
hippocampus; EC, entorhinal cortex; AM, amygdaloid com- 
plex: HT, hypothalamus; CER, cerebellum; SEP, septum; ST, 
striatum: L, lateral amygdaloid area; CM, central-medial 
amygdaloid; CO, cortical amygdaloid area: B, basal amygda- 
k)id area. 
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the range of tissue concentration used for estimates 
of binding density. Binding estimated by extrapola- 
tion from Scatchard plots was high in frontal cortex, 
intermediate in hippocampus, entorhinal cortex, 
amygdaloid complex and hypothalamus, and low in 
striatum, septum and brainstem (Fig. 1A). Estimates 
at fixed ligand concentration yielded a very similar 
pattern of binding density except for a slightly lower 
value for the hippocampus (Fig. 1B). Within the 
amygdaloid complex, binding was highest in the lat- 
eral sample (Fig. 1B). 
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Fig. 2. Effect of infusion of  chlordiazepoxide into the lateral 
amygdaloid complex on the rat conflict test (means _+ S .E .M . ,  
n = 1]) .  Dark  periods shaded, light periods unshaded. A:  sa- 
line control infusion (! #1 at 0.5#1 per rain). B: chk)rdiazcpox- 
ide infusion ( l(l#g in 1 #1 at O.5,ul per min); release effect signif- 
icant with respect to saline control (P < 0.001, Wilcoxon test). 
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Conflict test 
Acquisition was very rapid. Subjects showed sup- 
pression confined to the dark periods during the first 
training session, which after 8 sessions reached a sta- 
ble asymptotic level. Microinfusions of chlordiaze- 
poxide (10~g in 1 #1 saline at a rate of 0.5 #l '  min-~) 
into the lateral amygdaloid complex produced highly 
significant release of responding in the dark periods 
with no effect on responding in the light (Fig. 2). 
Control infusions of saline into the lateral amygda- 
loid complex, and of the same dose of chlordiazepox- 
ide to a site 1 mm dorsal to the amygdaloid complex 
produced no release (Fig. 3). The releasing effect of 
CDP was severely attenuated when the shocks nor- 
mally omitted on test days were instead included 
(P < 0.001, Wilcoxon; Fig. 3). The inclusion of 
shock did not however quite reduce responding to sa- 
line control levels (P < (l.01, Wilcoxon; Fig. 3). 
According to Myers ~6, the small, low-rate infusions 
used would be expected to produce a radial spread of 
about 0.5 mm from the site of infusion. The spread ~I 
an infusion of 1/A of [3H]diazepam stock (1() nM) into 
the lateral amygdaloid area was measured dirccdv. 
Samples dissected and frozen 5 rain after a standard 
infusion (1 #1 over 2 min) revealed approximately 
17,000 cpm of activity in the amygdaloid complex, 
compared to 300 cpm in the next highest region, the 
ventral hippocampus. 
Analgesia test 
An identical infusion of chlordiazepoxide into the 
lateral amygdaloid complex in the same group of 11 
rats had no effect on tail-flick latency when compared 
with saline vehicle (5.7 + 0.5 S.E.M. and 4.8 _+ 0.7 s, 
respectively; n.s., Wilcoxon test). 
DISCUSSION 
The binding results from this study are in striking 
agreement with the most recent findings based on 
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Fig. 3. Summary (means + S.E.M., n = 11) of the effects of intra-amygdaloid chlordiazepoxide on the rat conflict test f(~r all combina- 
tions of infusions, shock and placement tested. Compared with saline controls (SAL), chlordiazepoxide (CDP) infusions into the later- 
al amygdaloid complex (AL) significantly increased responding in the dark (shaded) periods in the absence (P < 0.001: Wilcoxon test) 
and presence (P < 0.005, Wilcoxon test) of shock. The central placement had no significant effect, and response vakies in the liglvt 
(unshaded) periods were also unaffected (all n.s., Wilcoxon test). 
autoradiographic mapping17 revealing the lateral 
area to have the highest density of [3H]diazepam 
binding within the amygdaloid complex. Microinfu- 
sions of a small dose of chlordiazepoxide into the lat- 
eral area of the amygdaloid complex produced a se- 
lective release of suppressed responding with no non- 
specific effects. This effect was not produced by ex- 
tra-amygdaloid infusions of chlordiazepoxide or of 
saline, and the effective intra-amygdaloid dose of 
chlordiazepoxide did not show any analgesic effect 
on the tail-flick test. Similar infusions using [3H]dia- 
zepam solution suggested that spread after 5 rain was 
minimal. Such a time-course and Myers' studies~6 ren- 
der it likely the infusion had its anxiolytic effect be- 
fore it had spread significantly beyond the site of in- 
jection. 
Peripheral administration of chlordiazepoxide has 
an identical releasing effect, recently shown to be 
blocked by the benzodiazepine antagonist Ro 
15-1788 (ref. 28). These findings strongly suggest 
that the lateral amygdaloid complex is a key site for 
the anxiolytic action of the benzodiazepines. 
The presence of shock greatly attenuated the re- 
leasing effect of CDP, indicating the release effect 
was specific to the conditioned emotional response 
(CER) and did not extend to behaviour suppressed 
by immediate punishment. Other actions of chlordia- 
zepoxide cannot account simply for the confinement 
of the release phenomenon to the dark (shock signal) 
period. Muscle relaxant or sedative actions would 
have produced further suppression of responding and 
neither of these actions would be predicted to be spe- 
cific to the dark periods. 
The wider neural mechanisms by which activation 
of benzodiazepine receptors in the amygdaloid com- 
plex produces a specific anti-anxiety effect are un- 
clear 2~. Recent anatomical s tud ies  ~.12,25,3~ have sup- 
ported earlier suggestions that the amygdaloid com- 
plex may be an important cortico-hippocampal re- 
lay -'-7. The lateral area of the amygdaloid area con- 
tains the lateral nucleus which receives projections 
from the neocortex and projects to the hippocampal 
formation ll. The lateral amygdaloid projection to the 
hippocampal system is known to have a strong mod- 
ulatory electrophysiological influence on the ento- 
rhinal input to the dentate gyrus 29.30. The population 
of benzodiazepine receptors in the lateral amygda- 
loid area is therefore in a position to modulate corti- 
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co-hippocampal neurotransmission, and this may be 
an important facet of the anxiolytic action of benzo- 
diazepines. 
In addition to its reciprocal links with the hippo- 
campal formation, the basolateral area of the amyg- 
daloid complex has prominent links with frontal cor- 
tex both directly and via the nucleus medialis dorsalis 
of the thalamus 10,20. Recent cytoarchitectural studies 
have also supported the notion that the lateral and 
basolateral areas of the amygdaloid complex play a 
critical role in coordinating lirnbic forebrain areas 
that direct behavioural output 13. Both the hippocam- 
pal formation and the amygdaloid complex send out- 
put to the nucleus accumbens septi s-9. 
Thus, different sectors of the amygdaloid complex 
project to hippocampus and to association cortex, a 
dissociation supported by the cytoarchitectural data. 
In turn, both the hippocampus and basolateral amyg- 
daloid complex project to the nucleus accumbens, 
which receives a rich dopaminergic innervation 12 and 
serves as an interface between limbic structures and 
motor output mechanisms of the striatum 1~. Both in 
terms of its interactions with circuits in the limbic sys- 
tem and its access to motor mechanisms, the amygda- 
Mid complex is viewed as a critical structure coordi- 
nating limbic forebrain areas that direct behavioural 
output. Lesion studies suggest that whereas the 
amygdaloid complex is critical for the coding of 
meaningful events, the hippocampus is involved m 
the memory of those events ~5. In the absence of these 
limbic structures, present experience fails to guide 
future hehaviour. 
One might speculate then that the amygdalo-hip- 
pocampal and amygdalo-frontal circuits, respective- 
ly, subserve the mnemonic and affective aspects of 
emotional experience, It is particularly striking that 
all of the key sites in this speculative scheme exhibit 
high local concentrations of benzodiazepine recep- 
tors. The strong agreement of biochemical, anatom- 
ical, physiological and behavioural data from this and 
other work suggests a prevalent role of benzodiaze- 
pine receptors in the amygdaloid and related limbic 
sites in anxiety. 
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